Theranostic role of89Zr/177Lu-labeled aflibercept in triple-negative breast cancer

被引：0
|
作者：
Kang, L. [1 ]
Yang, Q. [1 ]
Chen, Z. [1 ]
Qiu, Y. [1 ]
Huang, W. [1 ]
Song, L. [1 ]
机构：
[1] Peking Univ First Hosp, Beijing, Peoples R China
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2023年 / 50卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
OP-622
引用
收藏
页码：S282 / S283
页数：2
相关论文
共 50 条
  • [31] Role of the Androgen Receptor in Triple-Negative Breast Cancer
    Rampurwala, Murtuza
    Wisinski, Kari B.
    O'Regan, Ruth
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2016, 14 (03) : 186 - 193
  • [32] The role of the androgen receptor in triple-negative breast cancer
    Shah, Payal D.
    Gucalp, Ayca
    Traina, Tiffany A.
    WOMENS HEALTH, 2013, 9 (04) : 351 - 360
  • [33] Theranostic application of 64Cu/177Lu-labeled anti-Trop2 monoclonal antibody in pancreatic cancer tumor models
    Li, Cuicui
    Liu, Jun
    Yang, Xu
    Yang, Qi
    Huang, Wenpeng
    Zhang, Mingyu
    Zhou, Dandan
    Wang, Rong
    Gong, Jianhua
    Miao, Qingfang
    Kang, Lei
    Yang, Jigang
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 50 (01) : 168 - 183
  • [34] A Liposome Encapsulated Ruthenium Polypyridine Complex as a Theranostic Platform for Triple-Negative Breast Cancer
    Shen, Jianliang
    Kim, Han-Cheon
    Wolfram, Joy
    Mu, Chaofeng
    Zhan, Wei
    Liu, Haoran
    Xie, Yan
    Mai, Junhua
    Zhang, Hang
    Li, Zhi
    Guevara, Maria
    Mao, Zong-Wan
    Shen, Haifa
    NANO LETTERS, 2017, 17 (05) : 2913 - 2920
  • [35] Targeting Breast Cancer Using 177Lu-Labeled Trastuzumab and Trastuzumab Fragment First-in-Human Clinical Experience
    Rathore, Yogesh
    Lakhanpal, Tamanna
    Chakraborty, Sudipta
    Chakravarty, Rubel
    Mittal, B. R.
    Irrinki, R. N. Santhosh
    Laroiya, Ishita
    Kaur, Komalpreet
    Shukla, Jaya
    CLINICAL NUCLEAR MEDICINE, 2024, 49 (06) : e258 - e265
  • [36] A novel 177Lu-labeled Dual CA9-targeted Probe as a Potential Theranostic radiopharmaceutical for Hypoxic Colorectal Cancer Diagnosis and Therapy
    Guan, Siao-Syun
    Liao, Tse-Zung
    Lin, Kun-Liang
    Hsia, Chien-Chung
    Farn, Shiou-Shiow
    JOURNAL OF NUCLEAR MEDICINE, 2022, 63
  • [37] Theranostic application of 64Cu/177Lu-labeled anti-Trop2 monoclonal antibody in pancreatic cancer tumor models
    Cuicui Li
    Jun Liu
    Xu Yang
    Qi Yang
    Wenpeng Huang
    Mingyu Zhang
    Dandan Zhou
    Rong Wang
    Jianhua Gong
    Qingfang Miao
    Lei Kang
    Jigang Yang
    European Journal of Nuclear Medicine and Molecular Imaging, 2022, 50 : 168 - 183
  • [38] Theranostics using 89Zr/177Lu-labeled antibody targeting erythropoietin-producing hepatocellular A2 (EphA2)
    Watabe, Tadashi
    Iwasawa, Takumi
    Kimura, Hiroyuki
    Shirakami, Yoshifumi
    Naka, Sadahiro
    Kaneda, Kazuko
    Kobayashi, Takanori
    Omokawa, Marina
    Yagi, Yusuke
    Tomiyama, Noriyuki
    Kato, Kazunori
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2025,
  • [39] Insight into the Role of Phytochemicals in the Treatment of Triple-Negative Breast Cancer
    Maru, Devangkumar
    Kumar, Anmol
    MIDDLE EAST JOURNAL OF CANCER, 2023, 14 (02) : 189 - 203
  • [40] Insights into the Role of Estrogen Receptor β in Triple-Negative Breast Cancer
    Sellitto, Assunta
    D'Agostino, Ylenia
    Alexandrova, Elena
    Lamberti, Jessica
    Pecoraro, Giovanni
    Memoli, Domenico
    Rocco, Domenico
    Coviello, Elena
    Giurato, Giorgio
    Nassa, Giovanni
    Tarallo, Roberta
    Weisz, Alessandro
    Rizzo, Francesca
    CANCERS, 2020, 12 (06)
12345